GREEN CROSS HEALTH LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.01 NZD | +1.00% |
|
-.--% | -7.34% |
| 2023 | Green Cross Health Limited Declares an Interim Dividend, Payable on 20 December 2023 | CI |
| 2023 | Green Cross Health Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| Sales 2022 | 670M 400M | Sales 2023 | 494M 295M | Capitalization | 193M 115M |
|---|---|---|---|---|---|
| Net income 2022 | 24M 14.33M | Net income 2023 | 45M 26.86M | EV / Sales 2022 | 0.39 x |
| Net Debt 2022 | 72.29M 43.15M | Net Debt 2023 | 64.6M 38.56M | EV / Sales 2023 | 0.52 x |
| P/E ratio 2022 |
7.78
x | P/E ratio 2023 |
4.29
x | Employees | 5,700 |
| Yield 2022 |
4.89% | Yield 2023 |
5.19% | Free-Float | 21.74% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.00% | ||
| Current month | -0.98% | ||
| 1 month | -0.98% | ||
| 3 months | -17.21% | ||
| 6 months | -17.89% | ||
| Current year | -7.34% |
1 week
0.98
1.01
1 month
0.981.04
Current year
0.981.30
1 year
0.981.46
3 years
0.981.75
5 years
0.961.75
10 years
0.942.95
| Managers | Title | Age | Since |
|---|---|---|---|
Rachael Newfield
CEO | Chief Executive Officer | - | 18-10-29 |
Kalpana Goundar
DFI | Director of Finance/CFO | 40 | Dec. 03 |
Gary Safe
CTO | Chief Tech/Sci/R&D Officer | - | 09-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Bagnall
BRD | Director/Board Member | - | 09-09-29 |
Kimmitt Ellis
CHM | Chairman | - | 19-12-01 |
Peter Merton
BRD | Director/Board Member | 61 | 09-09-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 0.99 | -1.00% | 8,274 |
| 24-05-01 | 1 | -0.99% | 4,521 |
| 24-04-30 | 1.01 | +1.00% | 2,905 |
| 24-04-29 | 1 | -.--% | 5,757 |
| 24-04-26 | 1 | +2.04% | 5,308 |
End-of-day quote New Zealand S.E., April 29, 2024
More quotes
Green Cross Health Limited is a provider of primary healthcare services. The Company provides support, care and advice to its communities through its pharmacies, medical centers and community health services. The Company operates through two segments: pharmacy services and medical services. The pharmacy services segment provides retail and dispensary services, the medical services segment provides nursing and urgent care services. The Company offers pharmacy services through consolidated stores, equity accounted investments and franchise stores. The medical services segment includes fully owned and equity accounted medical centers, and support services provided to these medical centers, as well as medical centers. The Company's medical network provides general practice services across New Zealand with over 61 medical centers.
Sector
Drug Retailers
Calendar
2024-05-28
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.34% | 84.29M | |
| -12.79% | 8.6B | |
| +39.05% | 1.42B | |
| +8.27% | 435M | |
| -2.22% | 266M | |
| +10.56% | 224M | |
| -47.35% | 81.18M | |
| +23.75% | 62.38M |
- Stock Market
- Equities
- GXH Stock
